Abstract:Ethnopharmacological relevance: Morus alba L. is a widespread plant that has long been considered to have remarkable medical values, including anti-inflammation in Traditional Chinese Medicine (TCM). The components of Morus Alba L. constituents have been extensively studied and have been shown to have high prospects for cancer therapy. However, limited investigations have been done on the bioactive compounds in Morus alba L. Aim of the study: This study aimed to systematically examine the anticancer properties of 28 commercially available compounds from Morus alba L. against melanoma cells in vitro. Additionally, the anticancer mechanisms of the bioactive compound exhibiting the most significant potential were further studied. Materials and methods: The anti-proliferative effects of Morus alba L.-derived compounds on melanoma cells were determined by colony formation assays. Their effects on cell viability and apoptosis were determined using the CCK8 assay and flow cytometry, respectively. The binding affinity of identified Morus alba L. compounds with anticancer activities towards melanoma targets was analyzed via molecular docking. The molecular mechanism of Sanggenon C was explored using soft agar assays, EdU incorporation assays, flow cytometry, western blotting, transcriptome analysis, and xenograft assays. Results: Based on colony formation assays, 11 compounds at 20 mu M significantly inhibited colony growth on a panel of melanoma cells. These compounds displayed IC50 values (half maximal inhibitory concentrations) ranging from 5 mu M to 30 mu M. Importantly, six compounds were identified as novel anti-melanoma agents, including Sanggenon C, 3 '-Geranyl-3-prenyl-2 ',4 ',5,7-tetrahydroxyflavone, Moracin P, Moracin O, Kuwanon A, and Kuwanon E. Among them, Sanggenon C showed the most potent effects, with an IC50 of about 5 mu M, significantly reducing proliferation and inducing apoptosis in melanoma cells. Based on the xenograft model assay, Sanggenon C significantly inhibited melanoma cell proliferation in vivo. Sanggenon C triggered ER stress in a dose-dependent manner, which further disrupted cellular calcium ion (Ca2+) homeostasis. The Ca2+ chelator BAPTA partially restored cell apoptosis induced by Sanggenon C, confirming that Ca2+ signaling contributed to the anticancer activity of Sanggenon C against melanoma. Conclusions: In our study, 11 compounds demonstrated anti-melanoma properties. Notably, Sanggenon C was found to promote apoptosis by disrupting the intracellular calcium homeostasis in melanoma cells. This study provides valuable information for the future development of novel cancer therapeutic agents from Morus alba L.

Bioinformatic Study of the Active Compound of Morusin in Mulberry (Morus alba) against Breast Cancer

Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells.

Exploring the therapeutic and anti-tumor properties of morusin: a review of recent advances

Morusinol Extracted from Morus Alba Inhibits Cell Proliferation and Induces Autophagy Via FOXO3a Nuclear Accumulation-Mediated Cholesterol Biosynthesis Obstruction in Colorectal Cancer.

Gastrointestinal Cancer Therapeutics via Triggering Unfolded Protein Response and Endoplasmic Reticulum Stress by 2-Arylbenzofuran

Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer

Anti-Tumor Effect of Morusin from the Branch Bark of Cultivated Mulberry in Bel-7402 Cells Via the Mapk Pathway

Insilico Studies Unveiling the Hepatoprotective Potential of Morus alba Linn: Docking and ADMET Analysis

Antitumor Effect of Morusin via G1 Arrest and Antiglycolysis by AMPK Activation in Hepatocellular Cancer

Inhibition of Morusin from Mulberry Branches As an Agro-Waste to MDA-MB-453 and HCT116 Cancer Cells by Inducing Cell Apoptosis and Disturbing the Cell Cycle

Compounds Inhibiting Hyperglycemia and Cancer Cell Proliferation from Morus Alba L

Morusin Inhibits Breast Cancer-Induced Osteolysis by Decreasing Phosphatidylinositol 3-Kinase (Pi3k)-Mtor Signalling

Characterization of metabolism feature and potential pharmacological changes of morusin-a promising anti-tumor drug-by ultra-high-performance liquid chromatography coupled time-of-flight mass spectrometry and network pharmacology

Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition

Preparation of Morusin from Ramulus Mori and Its Effects on Mice with Transplanted H22 Hepatocarcinoma.

Morusin Induces Apoptosis and Autophagy Via JNK, ERK and PI3K/Akt Signaling in Human Lung Carcinoma Cells.

Screening of Anti-Melanoma Compounds from Morus Alba L.: Sanggenon C Promotes Melanoma Cell Apoptosis by Disrupting Intracellular Ca2+ Homeostasis.

Secondary metabolites of mulberry leaves exert anti-lung cancer activity through regulating the PD-L1/PD-1 signaling pathway

Morusinol extracted from Morus alba induces cell cycle arrest and apoptosis via inhibition of DNA damage response in melanoma by CHK1 degradation through the ubiquitin-proteasome pathway

Screening of anti-melanoma compounds from Morus alba L.: Sanggenon C promotes melanoma cell apoptosis by disrupting intracellular Ca 2+ homeostasis

Chemical Characterization of the Main Bioactive Polyphenols from the Roots of Morus Australis (Mulberry)